Brief: BELLUS Health To Present Clinical Data From Trial Of BLU-5937
10/10/2022 12:35
Oct 10 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH TO PRESENT CLINICAL DATA FROM PHASE 2B
SOOTHE
TRIAL OF BLU-5937 AT THE CHEST ANNUAL MEETING
Source text for Eikon: ID:nBw7qlYv4a
Further company coverage: BLU.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln